BTSG vs THC
BrightSpring Health Services, Inc. and Tenet Healthcare Corp., side by side — 4 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | BTSG | THC |
|---|---|---|
| Revenue | $12.9B | $21.3B |
| Net income | $190.7M | $2.4B |
| Gross margin | 11.8% | · |
| Net margin | 1.5% | 11.1% |
| Return on equity | 10.8% | · |
| Diluted EPS | $0.87 | $15.49 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $394.7M | $2.5B |
| Equity | $1.9B | $4.2B |
| Net debt / equity | 1.29× | 2.42× |
| Current ratio | 1.57× | 1.76× |
| Revenue CAGR 5y | · | 3.9% |
| Profit CAGR 5y | · | 25.2% |
THC bills 1.7× the revenue of BTSG, and keeps more of each dollar of revenue as profit (11.1% against 1.5%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
4 years side by side
| Fiscal year | BTSG | THC |
|---|---|---|
| FY2025 | $12.9B | $21.3B |
| FY2024 | $10.1B | $20.7B |
| FY2023 | $7.7B | $20.6B |
| FY2022 | $7.7B | $19.2B |
Bottom line
| Fiscal year | BTSG | THC |
|---|---|---|
| FY2025 | $190.7M | $2.4B |
| FY2024 | $-18.1M | $4.1B |
| FY2023 | $-154.6M | $1.3B |
| FY2022 | $-53.9M | $1.0B |
Standard deviation, each side
THC's net margin has been more volatile than BTSG's over the 4 comparable fiscal years — 5.7 percentage points of standard deviation against 1.3.
4 of 18 comparable fiscal years — a year missing data on either side is not counted.
Year by year
THC led in net margin in every one of the 4 comparable fiscal years — a structural lead, not a recent swing.
4 of 18 comparable fiscal years — a year missing data on either side is not counted.